BeStock  
Markets › Compare › CTKB vs OLMA

CTKB vs OLMA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
CTKB · Cytek Biosciences$5.34 ▼ 0.74%
OLMA · Olema Pharmaceuticals$7.94 ▲ 0.25%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

57131204278351Oct 9, '25Apr 9, '26Oct 7, '26
  • CTKB +35.5%
  • OLMA -25.7%

Head to head

MetricCTKBOLMA
Price$5.34$7.94
Change today▼ 0.74%▲ 0.25%
Market cap$694.11M$694.73M
Return, 3 months+16.3%-35.3%
Return, year to date+5.7%-68.2%
Return, 1 year+36.9%-26.0%
P/E (TTM)-8.5-3.7
P/B2.21.6
P/E percentile vs own 5y73rd51st
Dividend yield––
Revenue growth (YoY, latest qtr)+5.6%–
Net profit growth (YoY)-117.8%-44.3%
Gross margin53.2%–
Operating margin-21.6%–
Net margin-39.0%–
Return on equity-23.0%-52.7%
Analyst target vs. price+12.4%+317.8%
Analyst buy share33%100%
RSI (14)5026
30-day volatility55.5%45.6%
Max drawdown, 1 year-42.9%-77.9%
Trend readLeaning bullishStrong downtrend
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • OLMA is the largest of the group by market value.
  • CTKB has returned the most over the past year.
  • CTKB carries the lowest trailing P/E.
  • OLMA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top